Skip to main content
SpringerLink
Log in

SLE Epidemiology: Epidemiologic Subtypes and Risk Factors for Development

  • Chapter
  • First Online:
Lupus Erythematosus

  • 2073 Accesses

Abstract

While the etiology of systemic lupus erythematosus (SLE) is still enigmatic, epidemiologic research is continuously informing our understanding, with new insights into environmental risk factors and gene–environment interactions that play a role in disease susceptibility. SLE is a heterogeneous multisystem autoimmune disorder characterized by organ system manifestations which vary over time and autoantibodies that target mainly intracellular constituents. Antinuclear antibodies (ANA) are observed in over 95% of patients, while other characteristic autoantibodies [anti-double-stranded DNA (anti-dsDNA), anti-Smith (anti-Sm), anti-Ro, and anti-La antibodies] are less common. These autoantibodies have been detected years prior to first symptoms of SLE and are responsible for certain disease manifestations such as photosensitive rashes, cytopenias, thromboses, and glomerulonephritis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Sources

  1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

    Article  PubMed  CAS  Google Scholar 

  2. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.

    Article  PubMed  CAS  Google Scholar 

  3. Costenbader KH, Karlson EW, Mandl LA. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus. J Rheumatol. 2002;29(12):2545–50.

    PubMed  Google Scholar 

  4. Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am. 2005;31(2):245–54. vi.

    Article  PubMed  Google Scholar 

  5. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum. 2005;52(12):4003–10.

    Article  PubMed  CAS  Google Scholar 

  6. Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556–62.

    Article  PubMed  Google Scholar 

  7. Tucker LB, Uribe AG, Fernandez M, Vila LM, McGwin G, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008;17(4):314–22.

    Article  PubMed  CAS  Google Scholar 

  8. Sanchez-Guerrero J, Villegas A, Mendoza-Fuentes A, Romero-Diaz J, Moreno-Coutino G, Cravioto MC. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am J Med. 2001;111(6):464–8.

    Article  PubMed  CAS  Google Scholar 

  9. McCarty DJ, Manzi S, Medsger Jr TA, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995;38(9):1260–70.

    Article  PubMed  CAS  Google Scholar 

  10. Alarcon GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, McGwin G, Jr., Bartolucci AA, Roseman JM, Reveille JD. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999;8(3):197–209.

    Article  PubMed  CAS  Google Scholar 

  11. Vasudevan A, Krishnamurthy AN. Changing worldwide epidemiology of systemic lupus erythematosus. Rheum Dis Clin North Am. 2010;36(1):1–13. vii.

    Article  PubMed  Google Scholar 

  12. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15(5):308–18.

    Article  PubMed  CAS  Google Scholar 

  13. Bae SC, Fraser P, Liang MH. The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the “prevalence gradient hypothesis”. Arthritis Rheum. 1998;41(12):2091–9.

    Article  PubMed  CAS  Google Scholar 

  14. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 2007;56(4):1251–62.

    Article  PubMed  Google Scholar 

  15. Bernier MO, Mikaeloff Y, Hudson M, Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum. 2009;61(4):476–81.

    Article  PubMed  CAS  Google Scholar 

  16. Costenbader KH, Kim DJ, Peerzada J, Lockman S, Nobles-Knight D, Petri M, Karlson EW. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum. 2004;50:849–57.

    Article  PubMed  Google Scholar 

  17. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. J Rheumatol. 2001;28(12):2653–6.

    PubMed  CAS  Google Scholar 

  18. Cooper GS, Wither J, Bernatsky S, Claudio JO, Clarke A, Rioux JD, Fortin PR. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology. 2010;49(11):2172–80.

    Article  PubMed  CAS  Google Scholar 

  19. Parks CG, Walitt BT, Pettinger M, Chen JC, De Roos AJ, Hunt J, Sarto G, Howard BV. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the women’s health initiative observational study. Arth Care Res. 2011;63(2):184–94.

    Article  Google Scholar 

  20. Parks CG, Cooper GS, Nylander-French LA, Sanderson WT, Dement JM, Cohen PL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Hoppin JA, Savitz DA. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum. 2002;46(7):1840–50.

    Article  PubMed  Google Scholar 

  21. Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Fraser PA, Watts J, Pankey H, Karlson EW. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum. 2006;54(11):3648–54.

    Article  PubMed  Google Scholar 

  22. Sanchez-Guerrero J, Karlson EW, Colditz GA, Hunter DJ, Speizer FE, Liang MH. Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum. 1996;39(4):657–62.

    Article  PubMed  CAS  Google Scholar 

  23. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford). 1999;38(11):1130–7.

    Article  CAS  Google Scholar 

  24. Duran S, Apte M, Alarcon GS. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc. 2007;99(10):1196–8.

    PubMed  Google Scholar 

  25. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis. 2008;67(4):530–5.

    Article  PubMed  CAS  Google Scholar 

  26. Costenbader KH, Kang JH, Karlson EW. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol. 2010;172(2):205–16.

    Article  PubMed  Google Scholar 

  27. Bengtsson AA, Rylander L, Hagmar L, Nived O, Sturfelt G. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford). 2002;41(5):563–71.

    Article  CAS  Google Scholar 

  28. James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, Harley JB. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001;44(5):1122–6.

    Article  PubMed  CAS  Google Scholar 

  29. Peralta-Ramirez MI, Jimenez-Alonso J, Godoy-Garcia JF, Perez-Garcia M. The effects of daily stress and stressful life events on the clinical symptomatology of patients with lupus erythematosus. Psychosom Med. 2004;66(5):788–94.

    Article  PubMed  Google Scholar 

  30. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, Merrill JT, Sammaritano L, Lockshin M, Alarcon GS, Manzi S, Belmont HM, Askanase AD, Sigler L, Dooley MA, Von Feldt J, McCune WJ, Friedman A, Wachs J, Cronin M, Hearth-Holmes M, Tan M, Licciardi F. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142(12 Pt 1):953–62.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Epidemiology Unit, T2, Karolinska University Hospital, 171 76, Stockholm, Sweden

    Julia F. Simard Sc.D.

  2. Lupus Center, Brigham and Women’s Hospital, Boston, MA, USA

    Karen H. Costenbader M.D., M.P.H.

  3. Harvard Medical School, Boston, MA, USA

    Karen H. Costenbader M.D., M.P.H.

Authors
  1. Julia F. Simard Sc.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen H. Costenbader M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julia F. Simard Sc.D. .

Editor information

Editors and Affiliations

  1. Brigham and Women's Hospital, Harvard Medical School, Div. of Rheumatology/Immunology/Allergy, Francis Street 75, Boston, 02115, USA

    Peter H. Schur

  2. Div. of Rheumatology/Immunology/Allergy, Brigham and Women's Hospital, Lupus Center, Francis Street 75, Boston, 02115, Massachusetts, USA

    Elena M. Massarotti

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Simard, J.F., Costenbader, K.H. (2012). SLE Epidemiology: Epidemiologic Subtypes and Risk Factors for Development. In: Schur, P., Massarotti, E. (eds) Lupus Erythematosus. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1189-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1189-5_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1188-8

  • Online ISBN: 978-1-4614-1189-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation